FDA Panel Recommends New Peanut Allergy Treatment

The video discusses a new drug for peanut allergies, which involves taking capsules with small amounts of peanut powder to build tolerance. Intended for ages 4 to 17, the drug showed promising results in a study, with two-thirds of participants able to consume peanuts without symptoms. However, some experienced severe reactions, leading to dropouts. Peanut allergies affect over 1.6 million children in the US, and the FDA will decide on the drug's approval by January.

What percentage of participants were able to eat two peanuts without allergic symptoms?

What is the expected timeline for the FDA's final decision on the drug?